PIRAMAL ENTERPRISES LTD.

NSE : PELBSE : 500302ISIN CODE : INE140A01024Industry : Pharmaceuticals & DrugsHouse : Piramal Ajay

BSE2631.80-15.95 (-0.6 %)

PREV CLOSE (Rs.) 2647.75

OPEN PRICE (Rs.) 2650.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 43841

TODAY'S LOW / HIGH (Rs.)2564.10 2685.70

52 WK LOW / HIGH (Rs.)1178.85 2856.8

NSE2634.70-13.95 (-0.53 %)

PREV CLOSE( Rs. ) 2648.65

OPEN PRICE (Rs.) 2666.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 2634.70 (930)

VOLUME 1291344

TODAY'S LOW / HIGH(Rs.) 2562.30 2680.00

52 WK LOW / HIGH (Rs.)1178.55 2858

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

Stock Summary

Trade Value (Rs. in Lacs)

1147.97

Dividend Yield(%)

1.25

TTM EPS (Rs.)

2.95

P/E Ratio

891.07

Book Value (Rs.)

1055.32

Face Value (Rs.)

MCap (Rs. in Mn)

628114.95

Price/Earning (TTM)

484.13

Price/Sales (TTM)

24.20

Price/Book (MRQ)

2.49

PAT Margin (%)

1.37

ROCE (%)

3.77

company info

Incorporation Year : 26-04 1947

Management Info :

Ajay G Piramal - Chairman - Managing Director

Registered Office :

Address : Piramal Ananta Agastya Corporate Park ,Opposite Fire Brigade , Kamani Junction , L B S Marg ,Kurla ( W ),
Mumbai,
Maharashtra-400070

Phone : 022 3802 3000/4000

Email : complianceofficer.phl@piramal.com

Website : www.piramal.com

Registrars Details :

Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE, MCX

News

15Sep Piramal Enterprises informs about loss
Piramal Enterprises has informed that the Registrar and Transfer Agent o..

13Sep Piramal Enterprises informs about issu
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclo..

24Aug Piramal Enterprises informs about issu
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclo..

Financials

	QTR Jun 21	ANNUAL 21
Net Profit	531.300000000001	398.999999999997
Gross Profit	589.900000000001	-692.000000000003
Operating Profit	2474.2	12907.4
Net Sales	5127.8	18247

Rs. in Millions

Rolling Forward P/E (EOD)

Event Calendar

peer group

Hester Biosciences (BSE)

2524.10 (1.22%)

M.Cap (Rs. in Cr)2147.22

Kwality Pharma (BSE)

625.00 (2.45%)

M.Cap (Rs. in Cr)648.51

JB Chem & Pharma (BSE)

1739.10 (0.85%)

M.Cap (Rs. in Cr)13440.13

Aarti Drugs (BSE)

631.60 (2.35%)

M.Cap (Rs. in Cr)5848.62

Shareholding Pattern

	FI/BANKS/INSURANCE	8.33%
	PROMOTERS	43.52%
	NON-INSTITUTION	13.4%
	MUTUAL FUNDS/UTI	1.44%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name

Hold(%)

Navi Long Term Adva...

2.85

JM Value Fund(G)

2.78

DSP Arbitrage Fund-...

2.69

Union Midcap Fund-R...

2.58

Nippon India ETF Ju...

2.54

SBI-ETF Nifty Next ...

2.54

L&T Nifty Next 50 I...

2.54

ATTENTION INVESTORS|KYC|IPO|PROPRIETARY TRADING

Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors.

ATTENTION INVESTORS Advisory for Investors

1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.
2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
3. Pay 20% upfront margin of the transaction value to trade in cash market segment.
4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors

CORPORATE OFFICE

address

9/2003-4,
Vishnu Priya Limda Chowk
Main Road
Surat – 395 003.

call us @ +91-261-6673500 +91-261-2436536

fax us @ +91-261-6673537

email us @ info@rwadiwala.com

SEBI Regn No. BSE - CM/F&O, NSE - CM/F&O/CDS: INZ000187332 | SEBI PMS regn no.: INP000004045 | MCX & NCDEX SEBI Regn No.: INZ000080636 | CDSL DP ID: 12043100
| R Wadiwala Securities Pvt Ltd - CIN: U67120GJ2004PTC044324 | R Wadiwala Commodities Pvt Ltd - CIN: U51109GJ2007PTC050176

Compliance Officer - Email ID: compliance@rwadiwala.com | Contact No.: 0261-6673542

The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by us, our employees, and our servants.

Investor Greivance Redressal at support@rwadiwala.com

Designed & Developed by ●●● Accord Fintech Pvt. Ltd.

We are investment service provider for Buy stocks , Low Stocks Brokerage , Stocks Portfolio Management in Surat , NRI Investment in Stocks , Share Broking Surat , Stock Broking Surat , Advisory Services Surat and Competetive Stocks Brokerage.

PIRAMAL ENTERPRISES LTD.

Smart Quotes

Filing complaints on SCORES Easy & quick